VRE Screen: VR1708-1: Positive; VR1708-2: Positive; VR1708-3: Negative; VR1708-4: Negative – Shipped: Augsut 14, 2017
Participants’ results
| Challenge | Expected Results | Positive | Negative | Indeterminate, refer | Intermediate, refer | No report |
|---|---|---|---|---|---|---|
| VR1708-1 | VRE vanA positive | 16 (Acceptable) | 2 (Unacceptable) | 1 (Unacceptable) | ||
| VR1708-2 | VRE vanB positive | 10 (Acceptable) | 3 (Unacceptable) | 3 (Ungraded) | 1 (Acceptable) | 1 (Unacceptable) |
| VR1708-3 | Negative | 18 (Acceptable) | 1 (Unacceptable) | |||
| VR1708-4 | Negative | 18 (Acceptable) | 1 (Unacceptable) |
CMPT QC/QA/Statistics:
Samples VR1708-3 and -4 were E. faecalis van A & B negative, sample VR1708-1 was E. faecium van A positive, but van B negative and sample VR1708-2 was E.faecalis van B positive, but van A negative. All samples were homogeneous and stable for 26 days from the date of production, August 2, 2017.
All samples were produced by CMPT. Samples were randomly selected for QC/QA. Statistics are not applicable in qualitative surveys. CMPT results are listed in the above table.
CMPT is a program of the Department of Pathology and Laboratory Medicine. The University of British Columbia, Vancouver, B.C. Canada.